A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas
The purpose of the study is to see how effective JNJ-77242113 is in participants with plaque psoriasis affecting special areas (scalp, genital, and/or palms of the hands and the soles of the feet).
Inclusion Criteria:
Exclusion Criteria:
Fort Gratiot, Michigan 48059, United States
CABA, C1012AAY, Argentina
Caba, C1060ABN, Argentina
Borgyogyaszati Klinika, 7632, Hungary
Szeged, 6720, Hungary
Krakow, 30-002, Poland